TP53 and neoplasm: Recent research has indicated that wild-type p53 can promote ferroptosis in certain contexts (e.g., by repressing SLC7A11), whereas selected gain-of-function mutants may also sensitize tumor cells to ferroptosis, although many mutants confer resistance (70).